醇调节巨细胞中的DDIT4-mTOR信号通路,促进糖尿病伤口愈合
Kun Li1, Yingying Zhang1, Yunpeng Diao2
1College of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China.
International immunopharmacology
|February 23, 2025
概括
醇有效地治疗糖尿病足,通过促进M2巨分化和调节DDIT4-mTOR通路,减少炎症. 这为糖尿病伤口愈合提供了一个新的治疗策略.
科学领域:
- 生物医学科学 生物医学科学
- 伤口治愈研究研究 伤口治愈研究
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病足 (DFU) 是截肢的主要原因.
- 异常的M1/M2巨分化延长了DFU中的炎症.
- 在DFU中受损的伤口愈合需要新的治疗方法.
研究的目的:
- 为了研究 paeonol 对 M2 巨分化在 DFU 的影响.
- 为了确定M2巨细胞是否调节DDIT4-mTOR通路.
- 为了评估paeonol在缓解DFU炎症方面的潜力.
主要方法:
- 糖尿病足鼠标模型建立.
- 组织学染色 (HE,Masson) 和免疫光检测用于伤口评估.
- 网络药理学用于阐明机制.
- 对巨细胞极化和炎症标记物的分子分析 (q-PCR,ELISA,西斑).
主要成果:
- 在糖尿病小鼠中,Paeonol显著促进了伤口愈合.
- 醇增强了伤口组织中的原沉积和血管生成.
- 醇将巨细胞的表型转移到M2,通过DDIT4-mTOR通路激活来减少M1标记物和炎症因素.
结论:
- 醇促进M2巨细胞的两极分化,并加速DFU的愈合.
- DDIT4-mTOR信号通路是paeonol抗炎作用的关键机制.
- 帕埃诺尔为糖尿病足提供了一个有前途的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


